TMO vs MRNA
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Moderna, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | MRNA |
|---|---|---|
| Price | $700.22 | $223.37 |
| Market cap | $259.44B | $90.38B |
| P/E ratio | 36.9 | — |
| ROE | 13.38% | -34.50% |
| Profit margin | 14.94% | -110.45% |
| Revenue growth | 9.10% | 29.20% |
| Dividend yield | 0.27% | 0.00% |
| Beta | 0.84 | 1.17 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs MRNA in plain English
- TMO is the bigger company — about 2.9× the market cap of MRNA.
- TMO earns a higher return on equity (13% vs -35%).
- MRNA is growing revenue faster (29% vs 9%).
- TMO pays a dividend (0.27%) while the other effectively doesn't.
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
MRNA return calculator
See what $1,000 in Moderna, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.